The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma (ImpactCRT): A single-arm, phase Ⅱ trial.
 
Fang Peng
No Relationships to Disclose
 
Yong Bao
No Relationships to Disclose
 
Chao Cheng
No Relationships to Disclose
 
Shaoqing Niu
No Relationships to Disclose
 
Wu Song
No Relationships to Disclose
 
Yin Li
No Relationships to Disclose
 
Honglan Yu
No Relationships to Disclose
 
Xiangbin Xing
No Relationships to Disclose
 
Shiting Feng
No Relationships to Disclose
 
Xiaoyan Wang
No Relationships to Disclose
 
Huimin Lian
No Relationships to Disclose
 
Tiantian Yu
No Relationships to Disclose
 
Jialiang Wu
No Relationships to Disclose